Daniel Lynch - Nov 11, 2021 Form 4 Insider Report for 2seventy bio, Inc. (TSVT)

Role
Director
Signature
/s/ Teresa Jurgensen, Attorney-in-Fact
Stock symbol
TSVT
Transactions as of
Nov 11, 2021
Transactions value $
$0
Form type
4
Date filed
11/16/2021, 05:44 AM
Previous filing
Oct 21, 2021
Next filing
May 20, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction TSVT Common Stock Award $0 +2.8K +105.77% $0.00 5.45K Nov 11, 2021 Direct F1, F2, F3, F4

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction TSVT Stock Option (right to buy) Award $0 +7.66K $0.00 7.66K Nov 11, 2021 Common Stock 7.66K $8.55 Direct F5, F6
transaction TSVT Stock Option (right to buy) Award $0 +3.45K $0.00 3.45K Nov 11, 2021 Common Stock 3.45K $39.07 Direct F5, F6
transaction TSVT Stock Option (right to buy) Award $0 +3.45K $0.00 3.45K Nov 11, 2021 Common Stock 3.45K $287.25 Direct F5, F6
transaction TSVT Stock Option (right to buy) Award $0 +1.84K $0.00 1.84K Nov 11, 2021 Common Stock 1.84K $74.34 Direct F5, F6
transaction TSVT Stock Option (right to buy) Award $0 +1.84K $0.00 1.84K Nov 11, 2021 Common Stock 1.84K $172.37 Direct F5, F6
transaction TSVT Stock Option (right to buy) Award $0 +1.84K $0.00 1.84K Nov 11, 2021 Common Stock 1.84K $284.33 Direct F5, F6
transaction TSVT Stock Option (right to buy) Award $0 +1.84K $0.00 1.84K Nov 11, 2021 Common Stock 1.84K $189.47 Direct F5, F6
transaction TSVT Stock Option (right to buy) Award $0 +1.38K $0.00 1.38K Nov 11, 2021 Common Stock 1.38K $99.53 Direct F5, F6
transaction TSVT Stock Option (right to buy) Award $0 +4.51K $0.00 4.51K Nov 11, 2021 Common Stock 4.51K $50.98 Direct F5, F7
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 In connection with the separation (the "Separation") of seventy bio, Inc. ("2seventy") from bluebird bio, Inc. ("bluebird"), the reporting person received restricted stock units, each representing the right to receive a share of 2seventy's common stock, as a result of the adjustment of existing bluebird restricted stock units prior to the Separation (see footnotes 2 and 3). This restricted stock unit award vests 100% on the earlier of June 15, 2022 or the date of the next annual meeting of stockholders.
F2 bluebird equity awards granted prior to January 1, 2021 were converted into equity awards of both bluebird and 2seventy. The number of shares underlying the converted bluebird equity awards was determined by multiplying the number of shares underlying the existing bluebird equity award by a fraction, the numerator of which is the volume-weighted average trading price of bluebird common stock (trading "regular way") on the five trading days immediately prior to the distribution date (the "bluebird Pre-Distribution VWAP"), the denominator of which is the sum of (1) the volume-weighted average trading price of 2seventy common stock (trading "regular way") on the five trading days immediately following the distribution date (the "2seventy VWAP") multiplied by the distribution ratio and (2) the volume-weighted average trading price of bluebird common stock (trading "regular way") on the five trading days immediately following the distribution date (the "bluebird Post-Distribution VWAP").
F3 The number of shares underlying the converted 2seventy equity awards was determined by multiplying the number of shares underlying the existing bluebird equity awards by a fraction, the numerator of which is the bluebird Pre-Distribution VWAP and the denominator of which is the sum of (1) the 2seventy VWAP multiplied by the distribution ratio and (2) the quotient obtained by dividing the bluebird Post-Distribution VWAP by the distribution ratio. bluebird equity awards granted on or after January 1, 2021, such equity awards were converted into 2seventy equity awards. The number of shares of 2seventy common stock underlying such converted equity awards is equal to the number of shares of bluebird common stock subject to the equity award immediately prior to the distribution multiplied by a fraction, the numerator of which is the bluebird Pre-Distribution VWAP and the denominator of which is the 2seventy VWAP.
F4 Includes 2,650 shares of 2seventy's common stock received in a pro rata distribution by bluebird as a result of the Separation.
F5 Represents options to purchase shares of 2seventy's common stock granted to the reporting person in connection with the Separation (see footnotes 2 and 3).
F6 This option is fully vested and exercisable as of the date hereof (see footnotes 2 and 3).
F7 This option vests 100% on the earlier of June 15, 2022 or the date of the next annual meeting of stockholders (see footnotes 2 and 3).